XM does not provide services to residents of the United States of America.

Wall Street mixed as investors weigh GDP data after tech mauling



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street mixed as investors weigh GDP data after tech mauling</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

US economic growth regains steam in Q2; inflation slows

Ford slumps as higher costs, EV unit dent profit growth

IBM gets lift from software, AI demand as consulting slips

American Airlines recovers ground

Indexes: Dow up 0.28%, S&P down 0.08%, Nasdaq down 0.44%

Updated at 9:46 a.m. ET/ 1346 GMT

By Ankika Biswas and Lisa Pauline Mattackal

July 25 (Reuters) - Wall Street's main indexes were mixed on Thursday as investors assessed stronger-than-expected GDP data and remained cautious after suffering a tech mauling in the previous session.

Data showed the U.S. economy expanded 2.8% in the second quarter versus estimates of 2%, but inflation subsided, leaving intact expectations of a September rate cut.

"The growth rate was higher than what we were looking for, but the good news is that the economy expanded as consumers spent more as inflation dropped in the second quarter," said Peter Cardillo, chief market economist at Spartan Capital Securities.

"This is a good sign in terms of the economy."

Megacap stocks were mixed, after lackluster earnings from Alphabet GOOGL.O and Tesla TSLA.O pummeled the so-called "Magnificent Seven" group of tech stocks in the previous session. The Nasdaq .IXIC and the S&P 500 .SPX saw their worst day since 2022 in the selloff.

On Thursday, Nvidia NVDA.O, Alphabet GOOGL.O and Microsoft MSFT.O slipped between 0.4% and 0.9%, while Tesla rebounded2.6% after a 12% slump a day earlier.

Semiconductor stocks also broadly fell, led by a 13% tumble in Teradyne TER.O after the chip-testing equipment maker forecast lower-than-expected third-quarter revenue. The semiconductor index .SOX lost1.6%.

While the group of heavyweightstocks has poweredthe stock market to all-time highs this year,Wednesday's selloff added weight to fears thatthese stocks might be over-stretched and in for more turbulence.

"There is so much pull ahead in terms of share prices, earnings forecasts with AI that we are seeing some fatigue setting in," said Jake Dollarhide, chief executive officer at Longbow Asset Management.

The small-cap Russell2000 .RUT outperformed, rising0.7% after a2% slump in the prior session, as investors now see more value in shifting to lagging sectors.

Wall Street's "fear gauge" .VIX eased slightly, but hovered around its highest since April 19.

Investors are awaiting the personal consumption expenditures (PCE) price data, due on Friday, to confirm bets of an early start to the Federal Reserve's rate cuts after the recent trend of easing inflation and some weakness in the labor market.

Bets of a 25-basis-point cut in September ticked up to nearly 88% from around 78% prior to Thursday's data, as per CME's FedWatch Tool.

Market participants are also pricing in at least two rate cuts by December this year, according to LSEG data.

At 9:46 a.m. ET, the Dow Jones Industrial Average .DJI was up 111.84 points, or 0.28%, at 39,965.71, the S&P 500 .SPX was down 4.15 points, or 0.08%, at 5,422.98, and the Nasdaq Composite .IXIC was down 76.93 points, or 0.44%, at 17,265.48.


Among earnings-driven moves, FordF.N slumped17.2% after the automaker's second-quarter adjusted profit missed estimates by a wide margin, while American Airlines AAL.O rose4.5%, reversing premarket losses after cutting itsannual profit forecast.

Edwards Lifesciences EW.N tumbled 23.8%, the biggest decliner on the S&P 500,after missing second-quarter revenue estimates.

Advancing issues outnumbered decliners by a 1.84-to-1 ratio on the NYSE and by a 1.52-to-1 ratio on the Nasdaq.

The S&P index recorded 25 new 52-week highs and 8 new lows, while the Nasdaq recorded 45 new highs and 37 new lows.


S&P500 breaks calm streak with 2%+ drop https://tmsnrt.rs/3A8anwg


Reporting by Ankika Biswas, Lisa Pauline Mattackal and Medha Singh in Bengaluru; Editing by Savio D'Souza and Saumyadeb Chakrabarty

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.